Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Oct. 31, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 31, 2013

Ariad, Baxter, e-Therapeutics, Hyperion, Kamada, Mesoblast, Stem Cell Therapeutics, Teva

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Kamada reports preliminary pediatric diabetes data . . . read more

Phase II
e-Therapeutics starts trial of tramadol CR formulation . . . read more

Phase III
Teva gets approval for CHF trial . . . read more

Post-Approval
Hyperion begins UCD outcomes study . . . read more

Filings
Ariad suspends Iclusig marketing in U.S. . . . read more

Baxter submits Rixubis in EU . . . read more

Stem Cell Therapeutics gets Orphan status for tigecycline in AML . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics